Jiang Mingjin,Ph.D.

Nationality

Chinese

Ethnicity

Han

Hometown

Duchang, Jiangxi

Professional Title

Associate Chief Pharmacist

Position

Director, Postdoctoral Management Office, Department of Science and Technology

Supervisor Type

Master's Supervisor

E-mail

Mingjin.Jiang@ncu.edu.cn

Courses Taught

Pharmacology, Hospital Pharmacy, Medical Paper Writing

Research Interests

Neuropharmacology of Traditional Chinese Medicine (TCM); Neuropsychopharmacology;

Using models such as organoids and zebrafish for the screening and evaluation of active components in TCM.

Education

Bachelor of Science, Major of Chinese Materia Medica, Jiangxi University of Traditional Chinese Medicine, Sep 2006-Jul 2010;

Master of Medicine, Major of Chinese Materia Medica, Southern Medical University, Sep 2010-Jul 2013;

PhD of Medicine, Major of Chinese Materia Medica, Southern Medical University, Sep 2013-Jul 2016.

Work Experience

Pharmacist-in-charge, Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Jul 2016-Mar 2021;

Deputy Director, Jiangxi Provincial Institute of Translational Medicine, The First Affiliated Hospital of Nanchang University, Mar 2021-Jun 2023;

Director, Postdoctoral Management Office, Department of Science and Technology, The First Affiliated Hospital of Nanchang University, Jun 2023-Present.

Academic Positions

Member of the Youth Committee, Society of Medical Science Research Management, Chinese Medical Association;

Member, Society of Hospital Pharmacy, Chinese Association of Chinese Medicine;

Chief Supervisor, Jiangxi Provincial Geriatrics Society;

Alternate Chairman, Society of Medical Science Research Management, Jiangxi Provincial Medical Association;

Standing Committee Member, Society of Chinese Materia Medica and Natural Medicines, Jiangxi Provincial Pharmaceutical Association.

Honors & Awards

Jiangxi Provincial Young and Middle-aged Key Talent in TCM;

Ganjiang Young Scholar;

Youth Academic Leader of the First Affiliated Hospital of Nanchang University.

Major Achievements

1. Research Projects (Principal Investigator):

[1] Key Project of Jiangxi Provincial Key R&D Program (2026-2028): “Study on the Screening and Evaluation of Traditional Chinese Medicine Based on Human Liver Organoid Disease Models” RMB 800,000.

[2] National Administration of Traditional Chinese Medicine (2026-2028): “National Inheritance Workshop for Veteran Traditional Chinese Pharmacists” RMB 500,000.

[3] Natural Science Foundation of Jiangxi Province (2026-2028) “Study on the Effect and Mechanism of Rhynchophylline on Methamphetamine Addiction by Inhibiting Microglia-mediated Neuroinflammation” RMB 100,000.

[4] Jiangxi Medicine Academy of Nutrition and Health Management (2024-2027): “Immunomodulatory mechanism of peach gum polysaccharide based on gut immunity” RMB 200,000.

[5] Jiangxi Provincial Administration of Traditional Chinese Medicine (2022-2024): “Jiangxi Provincial Young and Middle-aged Key Talent in Traditional Chinese Medicine” RMB 150,000.

[6] Natural Science Foundation of China (2018-2021): “Study the effect and mechanism of rhynchophylline on improving methamphetamine-induced cognitive impairment based on the miR-124/NF-κB/AMPAR axis” RMB 340,000.

[7] Natural Science Foundation of Jiangxi Province (2019-2021): “MiR-124 involves in methamphetamine-induced cognitive impairment by

inhibiting neuroinflammation” RMB 60,000.

[8] Natural Science Foundation of Jiangxi Province (2017-2020): “MiR-181a-5p in the hippocampus involves in methamphetamine addiction by suppressing GABRA1 and the interventional effects of rhynchophylline” RMB 60,000.

2. Representative Publications (First/Corresponding Author):

[1] Chuanhua Feng*, Xiaolin Tang, Jian Zhou, Huiling Guo, Jinfang Hu, Guosong Zhang*, Mingjin Jiang*. Deep eutectic solvent: improve the constituents in Plantago asiatica L. (PAL) extract oral absorption in rats. Chemistry & biodiversity, 2025, e01611. Advance online publication. https://doi.org/10.1002/cbdv.202501611

[2] Jialing Shan, Weiqiong Hu, Qin Xie, Wei Bai, Tianyu Hu, Yanni Lv, Mingjin Jiang*. Exploring the mechanism of Sini San formula on ulcerative colitis and depression through “homotherapy for heteropathy” based on network pharmacology and molecular docking. Traditional Chinese Drug Research & Clinical Pharmacology, 2024; 35(1): 83-91.

[3] Mingjin Jiang, Jing Li, Chaohua Luo, Chen Zhu, Zhijie Chen, Wei Bai, Tianyu Hu, Chuanhua Feng, Chan Li*, Zhixian Mo*. Rhynchophylline inhibits methamphetamine dependence via modulating the miR-181a-5p/GABRA1 axis. Journal of Ethnopharmacology, 2023; 314: 116635.

[4] Mingjin Jiang, Zhu WangYanni Lv, Jianlan Hu, Jinfang Hu*. Rhynchophylline inhibits methamphetamine-induced addiction in rat pheochromocytoma cells by regulating microRNA-181a. Chinese Journal of Clinical Pharmacology, 2022; 38(17): 2055-2059.

[5] Mingjin Jiang, Jinhua Wen, Decheng Pan, Jian Zhou, Yanni Lv, Xiaohua Wei*. Structure and function of SARS-CoV-2 spike protein and its receptor. Chinese Pharmacological Bulletin, 2020; 36(11): 1497-1501.

[6] Mingjin Jiang, Duanwen Cao, Jian Zhou, Yanni Lv, Yaling Qiu, JinhuaWen, Xiaohua Wei*. MiR-124 involves in methamphetamine addiction in PC12 cells by inhibiting GluR2. Chinese Pharmacological Bulletin, 2017; 33(7): 982-986.

[7] Mingjin Jiang^#, Yifei Chen^#, Chan Li, Qiuxian Peng, Miao Fang, Wei Liu, Qunzhao Kang, Yingbo Lin, Ken Kin Lam Yung, Zhixian Mo*. Inhibiting effects of rhynchophylline on zebrafish methamphetamine dependence are associated with amelioration of neurotransmitters content and down-regulation of TH and NR2B expression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2016, 68: 31-43.

[8] Mingjin Jiang, Xiaohua Wei, Jinhua Wen, Zhixian Mo*. The study of sinomenine and methadone on the cardiotoxicity in zebrafish embryos. Pharmacology and Clinics of Chinese Materia Medica, 2016; 32(6): 70-72.

[9] Mingjin Jiang, Chan Li, Yingbo Lin, Daoqi Zhu, Zhixian Mo*. Research progress on the role of miRNAs in amphetamine-type stimulants addiction. Chinese Pharmacological Bulletin, 2015; 31(10): 1352-1355.

[10] Mingjin Jiang^#, Jing Li^#, Qiuxian Peng^#, Yi Liu, Wei Liu, Chaohua Luo, Ju Peng, Junkui Li, Ken Kin Lam Yung*, Zhixian Mo*. Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. Journal of Neuroinflammation, 2014, 11: 167.